BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

996 related articles for article (PubMed ID: 32977128)

  • 21. Is venous thromboembolism a predictable marker in older patients with COVID-19 infection? A single-center observational study.
    De Giorgi A; Contini C; Greco S; Fabbian F; Gasbarro V; Zuliani G; Passaro A; Zenunaj G; Manfredini R
    J Infect Dev Ctries; 2021 May; 15(5):639-345. PubMed ID: 34106886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of venous thromboembolism in patients with COVID-19 in an underserved urban population: A single tertiary center experience.
    Barnes DH; Lo KB; Bhargav R; Gul F; DeJoy R; Peterson E; Salacup G; Pelayo J; Albano J; Azmaiparashvili Z; Rangaswami J; Carpio AM; Patarroyo-Aponte G
    Clin Respir J; 2021 Aug; 15(8):885-891. PubMed ID: 33864721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality and bleeding complications of COVID-19 critically ill patients with venous thromboembolism.
    Gil-Sala D; Riera C; García-Reyes M; Rodríguez M; Marrero CE; Martínez L; Gil M; Ruiz-Rodríguez JC; Ferrer R; DE Nadal M; Suito-Alcántara MA; Llagostera S; Bellmunt-Montoya S
    Int Angiol; 2022 Feb; 41(1):1-8. PubMed ID: 34751541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19).
    Al-Samkari H; Song F; Van Cott EM; Kuter DJ; Rosovsky R
    Am J Hematol; 2020 Dec; 95(12):1479-1485. PubMed ID: 32780525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
    Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
    Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of inflammatory and coagulation biomarkers for venous thromboembolism in COVID-19 patients.
    Hojker M; Tršan J; Tršan U; Gale A; Jerman A; Košuta D
    Clin Hemorheol Microcirc; 2023; 83(4):387-395. PubMed ID: 36683498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
    Choi JJ; Wehmeyer GT; Li HA; Alshak MN; Nahid M; Rajan M; Liu B; Schatoff EM; Elahjji R; Abdelghany Y; D'Angelo D; Crossman D; Evans AT; Steel P; Pinheiro LC; Goyal P; Safford MM; Mints G; DeSancho MT
    Thromb Res; 2020 Dec; 196():318-321. PubMed ID: 32977130
    [No Abstract]   [Full Text] [Related]  

  • 30. Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis.
    Sarfraz A; Sarfraz Z; Razzack AA; Patel G; Sarfraz M
    Clin Appl Thromb Hemost; 2021; 27():1076029621993573. PubMed ID: 33571009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated levels of soluble fibrin in patients with venous thromboembolism.
    Tsuji A; Wada H; Matsumoto T; Abe Y; Ota S; Yamada N; Sugiyama T; Sudo A; Onishi K; Nakatani K; Uchida A; Ito M; Suzuki K; Nobori T
    Int J Hematol; 2008 Nov; 88(4):448-453. PubMed ID: 18836793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous thromboembolic events in patients with COVID-19: a systematic review and meta-analysis.
    Wu T; Zuo Z; Yang D; Luo X; Jiang L; Xia Z; Xiao X; Liu J; Ye M; Deng M
    Age Ageing; 2021 Feb; 50(2):284-293. PubMed ID: 33201226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and laboratory characteristics of patients with novel coronavirus disease-2019 infection and deep venous thrombosis.
    Motaganahalli RL; Kapoor R; Timsina LR; Gutwein AR; Ingram MD; Raman S; Roberts SD; Rahman O; Rollins D; Dalsing MC
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):605-614.e2. PubMed ID: 33190816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study.
    Gonçalves FAR; Besen BAMP; Lima CA; Corá AP; Pereira AJR; Perazzio SF; Gouvea CP; Fonseca LAM; Trindade EM; Sumita NM; Duarte AJDS; Lichtenstein A; ; Bonfa E; Utiyama EM; Segurado AC; Perondi B; Miethke-Morais A; Montal AC; Harima L; Fusco SRG; Silva MF; Rocha MC; Marcilio I; Rios IC; Kawano FYO; Jesus MA; Kallas ÉG; Carmo C; Tanaka C; Souza HP; Marchini JFM; Carvalho C; Ferreira JC; Levin ASS; Oliveira MS; Guimarães T; Lázari CDS; Sabino E; Magri MMC; Barros-Filho TEP; Francisco MCPB; Costa SF
    Clinics (Sao Paulo); 2021; 76():e3547. PubMed ID: 34909913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
    Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
    J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.
    Yu B; Li X; Chen J; Ouyang M; Zhang H; Zhao X; Tang L; Luo Q; Xu M; Yang L; Huang G; Liu X; Tang J
    J Thromb Thrombolysis; 2020 Oct; 50(3):548-557. PubMed ID: 32524516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation.
    Trigonis RA; Holt DB; Yuan R; Siddiqui AA; Craft MK; Khan BA; Kapoor R; Rahman O
    Crit Care Med; 2020 Sep; 48(9):e805-e808. PubMed ID: 32618699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Estimation of venous thromboembolism risk with thrombotic biomarkers in cancer patients].
    Jianlong M; Diansheng Z; Jing R
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):283-9. PubMed ID: 26462893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose response relationship between D-dimer level and mortality in critically ill COVID-19 patients: a retrospective observational study.
    Aditianingsih D; Soenarto RF; Puiantana AM; Pranata R; Lim MA; Raharja PAR; Birowo P; Meyer M
    F1000Res; 2022; 11():269. PubMed ID: 38665691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study.
    Chocron R; Duceau B; Gendron N; Ezzouhairi N; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Pommier T; Bory O; Cellier J; Philippe A; Geneste L; Ben Abdallah I; Panagides V; El Batti S; Marsou W; Juvin P; Deney A; Messas E; Attou S; Planquette B; Mika D; Gaussem P; Fauvel C; Diehl JL; Pezel T; Mirault T; Sutter W; Sanchez O; Bonnet G; Cohen A; Smadja DM;
    Arch Cardiovasc Dis; 2021 May; 114(5):381-393. PubMed ID: 33846096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.